FAST
Disease site: Breast Cancer
Treatment Modality: Radiotherapy
Status: In active follow-up
The FAST trial aims to test 5 fractions of 5.7 Gy and 6.0 Gy against 25 fractions of 2.0 Gy in terms of late normal tissue effects and tumour control in women prescribed whole breast radiotherapy (no boost) after local excision of early breast cancer. 915 patients were recruited into the trial between October 2004 and March 2007. 19 UK centres participated in the trial.
Chief Investigator: Prof John Yarnold, Royal Marsden Hospital.
Source of funding: Cancer research UK core funding.
ISRCTN: 62488883.
In the Clinical Trials Section
